Phase Objectives
Phase III Report: At the end of Phase III, all teams are expected to revise and update their previous submissions into a more complete report. By the end of Phase III, the report should contain at least the following sections:
The length of this report is expected to be equivalent to around 5 pages of 12 pt single-spaced text, not counting any figures, tables, or bibliography sections. As always, it is expected to conform to a medical journal or technical report style and be submitted as a pdf following the team number and shortened title naming convention, e.g. “Team 01 - Analysis of Breast Cancer Readmission.pdf”. Additional material can be included as a single (or zipped directory) supplementary file.
Report Evaluation: Submissions will be evaluated by faculty and peers on the following: